Metformin lowers age-related macular degeneration risk
Research, presented at the American Academy of Ophthalmology Meeting, suggests that patients with type-2 diabetes who use metformin lower their risk of developing age-related macular degeneration. Med Page Today
Source: Society for Endocrinology - Category: Endocrinology Source Type: news
More News: Academies | Age-Related Macular Degeneration (AMD) | Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Metformin | Opthalmology